Position in VRTX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$30,797
+$3,112 QoQ
Shares Held
62
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,563
of 1,735 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Canton Hathaway, LLC holds $783,315 across 6 Biotechnology names. VRTX ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BHVN |
Biohaven Ltd.
|
22,600 | $336,288 | |
| 2 | INCY |
Incyte Corp
|
1,500 | $170,040 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
1,000 | $122,580 | |
| 4 | CHRS |
Coherus Oncology, Inc.
|
58,230 | $81,522 | |
| 5 | MRNA |
Moderna, Inc.
|
601 | $42,088 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
62 | $30,797 |
All Filings in VRTX
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $30,797 | 62 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $27,685 | 62 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $28,108 | 62 | Shares | Sole | 2026-01-21 | |
| 2025-09-30 | $24,281 | 62 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $27,602 | 62 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $30,058 | 62 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $24,967 | 62 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $28,834 | 62 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $29,060 | 62 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $25,916 | 62 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $25,227 | 62 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $21,559 | 62 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $21,818 | 62 | Shares | Sole | 2023-07-11 | |
| No filing history on record for this holder in this stock. | ||||||